HCP Inc (HCP)
Financial | REIT - Healthcare Facilities
CEO: Thomas M. Herzog
HCP Inc receives a in our proprietary ranking system that combines valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. HCP Inc's valuation score is comprised of a P/E ratio of 15.5x, a P/B ratio of 2.6x, a P/S ratio of 7.3x, and an EV/EBITDA ratio of 27.8x. .
WARREN BUFFETT RANKING
HCP Inc ranks 314 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a average score, meaning it ranks in the middle of the pack on valuation, moat, volatility, and financial strength factors.
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet.
Interest coverage of 0x, a debt/equity ratio of 132% and a Moat Rank of 438 translate to a weak Financial Strength score.
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors. The company has seen its stock appreciate by 10.32% over the last 12 months. This performance is average compared to other stocks in the S&P 500, earning it a rank of 277.
VALUE + YIELD
Shares currently yield 5.96%. Our dividend ranking approach looks at a company's dividend growth rate, payout ratio, business moat, and valuation. Based on our methodology, HCP Inc ranks 405 among the S&P 500 constituents.
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. Its 0.9% 5 year annualized EPS growth, 4.3% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of -11.2% speak to its relatively poor ranking.